Cardiol Therapeutics Inc. Weighted Average Share Price Share Options Granted2019
Cardiol Therapeutics Inc. (CRDL) reported Weighted Average Share Price Share Options Granted2019 of 1.42 CAD/shares for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 · last filed 2026-03-31
| Period end | Weighted Average Share Price Share Options Granted2019 12 month |
|---|---|
| 2025-12-31 | 1.42 CAD/shares 40-F · filed 2026-03-31 |
| 2024-12-31 | 2.78 CAD/shares 40-F · filed 2026-03-31 |
| 2023-12-31 | 1.09 CAD/shares 40-F · filed 2025-03-31 |
| 2022-12-31 | 2.34 CAD/shares 20-F · filed 2024-04-01 |
| 2021-12-31 | 4.04 CAD/shares 20-F · filed 2024-04-01 |
| 2020-12-31 | 2.68 CAD/shares 20-F · filed 2023-03-29 |